Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2005
03/03/2005US20050048121 Sustained release; acylation, dehydration a diacid in presence of nonaqueous solvent
03/03/2005US20050048120 Sustained release; interior lipophilic membrane; hydrophilic exterior membrane containing peptide
03/03/2005US20050048119 Core containing antihypoglycemic agent with water soluble seal coating and semipermeable membrane
03/03/2005US20050048118 Core containing lipophilic matric with drug; protective coatings
03/03/2005US20050048116 Porous drug matrices and methods of manufacture thereof
03/03/2005US20050048115 Buprenorphine microspheres
03/03/2005US20050048114 Antibiotic product, use and formulation thereof
03/03/2005US20050048113 In situ administering of antisecretory agents and antacid
03/03/2005US20050048112 Solid pharmaceutical dosage form
03/03/2005US20050048111 Atopic dermatitis treatment method
03/03/2005US20050048110 Polymersomes and related encapsulating membranes
03/03/2005US20050048109 Non-polar photosensitizer formulations for photodynamic therapy
03/03/2005US20050048108 Using cephalins as complexing agent for gene therapy, diagnosis
03/03/2005US20050048107 Administering as a transdermal patch comprising oxybutynin to provide a plasma area under the curve (AUC) ratio of oxybutynin to an oxybutynin metabolite of from about 0.5:1 to about 5:1 with a peak oxybutynin metabolite plasma concentration of less than about 8 ng/ml
03/03/2005US20050048106 Administering as a transdermal patch comprising oxybutynin to provide a plasma area under the curve (AUC) ratio of oxybutynin to an oxybutynin metabolite of from about 0.5:1 to about 5:1 with a peak oxybutynin metabolite plasma concentration of less than about 8 ng/ml
03/03/2005US20050048104 Transdermal drug delivery devices comprising a polyurethane drug reservoir
03/03/2005US20050048103 Hydrophilic and hydrophobic polymer blend; crosslinking; drug delivery
03/03/2005US20050048102 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
03/03/2005US20050048101 Plaster for topical use containing heparin and diclofenac
03/03/2005US20050048099 Ocular implant made by a double extrusion process
03/03/2005US20050048098 Semirigid eye implant; glycolic acid-lactic acid copolymer and release moderator for dexamethasome;
03/03/2005US20050048097 Osmotic engine, cylinder membrane plug; fluid flow
03/03/2005US20050048089 Topical delivery system containing colloidal crystalline arrays
03/03/2005US20050048088 Compositions comprising at least two nanoemulsions
03/03/2005US20050048087 Mixture of fatty ester, lipophilic excipient and nonionic surfactant as solubilizer for drugs such as cyclosporin a and cyclosporin g; bioavailability
03/03/2005US20050048086 Oral administering; gastric retension; drug delivery
03/03/2005US20050048049 A humanized antibody that binds to soluble A beta; may be monoclonal, polyclonal, single chain or fused to a heterologous polypeptide
03/03/2005US20050048044 Controlling, adjustment diffusion or degradation of membrane using activating energy source such as light source or ultraviolet radiation
03/03/2005US20050048026 Remedies for ischemic diseases
03/03/2005US20050048024 Compounds for use as surfactants
03/03/2005US20050048002 Method for delivering drugs to the brain
03/03/2005US20050048001 Aerosol form; dissolved in fluorohydrocarbon; canister containing valve; inhalation therapy
03/03/2005US20050047958 Methods for sterilizing preparations of digestive enzymes
03/03/2005US20050045592 ultra-nanocrystalline diamond coated microchip drug delivery substrate that is impermeably sealed and inert for implantation in a living body
03/03/2005US20050045480 Valve for controlling flow of a fluid
03/03/2005US20050045197 Multiple drug delivery system & method
03/03/2005DE19853286B4 Verfahren zum Steuern eines chemischen Ventiles A method of controlling a chemical valve
03/03/2005DE10331879A1 Wirkstofftransportsystem Drug delivery system
03/03/2005DE102004028415A1 Dermales oder transdermales therapeutisches System enthaltend eine Abdeckfolie mit Barrierewirkung The dermal or transdermal therapeutic system comprising a cover sheet with barrier effect
03/03/2005CA2848954A1 Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants
03/03/2005CA2776692A1 Penetrating pharmaceutical foam
03/03/2005CA2536816A1 Method for deterring abuse of opioids by combination with non-release formulation of emetic
03/03/2005CA2536414A1 Novel formulation of ropinirole
03/03/2005CA2536283A1 Pharmaceutical preparations having an improved solubility
03/03/2005CA2536053A1 Powder formulation comprising the cgrp antagonist 1-(n2-(3,5-dibromo-n-(4-(3,4-dihydro-2(1h)-oxoquinazolin-3-yl)- 1-piperidinyl)carbonyl)-d-tyrosyl)-l-lysyl)-4-(4-pyridinyl)-piperazine
03/03/2005CA2536050A1 Novel inhalation powder comprising the cgrp antagonist 1-[n2-[3,5-dibromo-n-[[4-(3,4-dihydro-2(1h)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-d-tyrosyl]-l-lysyl]-4-(4-pyridinyl)-piperazine
03/03/2005CA2536048A1 Microparticles comprising the cgrp antagonist 1-[n2-[3,5-dibromo-n-[[4-(3,4-dihydro-2(1h)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-d-tyrosyl]-l-lysyl]-4-(4-pyridinyl)-piperazine method for production and use thereof as inhalation powder
03/03/2005CA2536047A1 Spray-dried amorphous bibn 4096 method for production and use thereof as inhalant
03/03/2005CA2535945A1 Topical delivery system containing colloidal crystalline arrays
03/03/2005CA2535810A1 Tablet containing 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethylester or the salts thereof
03/03/2005CA2535803A1 Compositions for delivering 5-ht agonists across the oral mucosa and methods of use thereof
03/03/2005CA2535571A1 Composition for treatment of tinea pedis and method of use
03/03/2005CA2535346A1 Active agent delivery systems, including a single layer of a miscible polymer blend, medical devices, and methods
03/03/2005CA2535345A1 Active agent delivery systems including a miscible polymer blend, medical devices, and methods
03/03/2005CA2535063A1 Medicament preparations for transdermal application containing active ingredient combinations for treating parkinson's disease
03/03/2005CA2533453A1 Thermal treatment to improve intraocular lens inserter lubricity
03/02/2005EP1510246A2 Method and apparatus for emulsification
03/02/2005EP1510225A2 Photochemotherapeutic and diagnostic application using 5-ALA and precursors
03/02/2005EP1510224A1 In vivo gene transfer methods for wound healing
03/02/2005EP1510223A1 Intravenous composition, process for producing the same and preparation thereof
03/02/2005EP1510220A1 Therapeutic inhibitor of vascular smooth muscle cells
03/02/2005EP1510215A1 Novel solid preparation containing block copolymer and anthracycline anticancer agent and process for producing the same
03/02/2005EP1510213A2 Penetration enhancing and irritation reducing systems comprising testosterone
03/02/2005EP1510206A1 Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs
03/02/2005EP1510205A1 Universal controlled-release composition comprising xanthan gum and sodium alginate
03/02/2005EP1509612A2 Transcellular drug delivery system
03/02/2005EP1509268A1 Drug delivery assembly
03/02/2005EP1509255A1 Methods and compositions for intravesical therapy of bladder cancer
03/02/2005EP1509246A2 Thermosensitive polymer carriers having a modifiable physical structure for biochemical analysis, diagnosis, and therapy
03/02/2005EP1509243A1 Topical drug delivery using phosphatidylcholine
03/02/2005EP1509237A2 Methods of treating angiogenesis, tumor growth, and metastasis
03/02/2005EP1509234A1 Treatment of mucositis
03/02/2005EP1509233A1 Liquid formulation of decitabine and use of the same
03/02/2005EP1509227A1 A buffered, liquid nicotine composition for pulmonary administration
03/02/2005EP1509223A1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin
03/02/2005EP1509211A1 Solubilisation of drugs in hfa propellant by means of emulsions
03/02/2005EP1509210A1 Plaster containing fentanyl
03/02/2005EP1509209A1 Compositions and method for transmucosal drug delivery and cryoprotection
03/02/2005EP1509208A1 Hydrodynamically balancing oral drug delivery system with biphasic release
03/02/2005EP1509207A1 Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release
03/02/2005EP1509206A1 A hemostatic composition
03/02/2005EP1509205A1 Pharmaceutical composition having a delayed active substance release, and method for the preparation thereof
03/02/2005EP1509204A1 Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose
03/02/2005EP1509203A2 Delivery of nucleic acid-like compounds
03/02/2005EP1509202A1 Novel high viscosity embolizing compositions comprising prepolymers
03/02/2005EP1509201A1 Film-shaped preparations with improved chemical stability containing active substances and method for the production thereof
03/02/2005EP1509200A1 Film-shaped, dissolvable preparations for active substance release and method for the production thereof
03/02/2005EP1509199A1 Dry powder inhalant composition
03/02/2005EP1509183A1 Delivery system for flowable medicinal or therapeutic substances
03/02/2005EP1509182A1 Implantable polymeric device for sustained release of buprenorphine
03/02/2005EP1421115B1 Soluble t cell receptor
03/02/2005EP1416966A4 Methods for treating joint inflammation, pain, and loss of mobility
03/02/2005EP1345591B1 Pharmaceutical aerosol formulation
03/02/2005EP1296650B1 Methods and compositions for treating pain of the mucous membrane
03/02/2005EP1282690B9 Isolation of precursor cells and their use for tissue repair
03/02/2005EP1244728B1 Microcrystalline cellulose cushioning granules
03/02/2005EP1219661B1 Block copolymer having polymer segment derived from oxazoline
03/02/2005EP1180018B1 Use of antiseptics in the manufacture of a pharmaceutical preparation for the prevention and treatment of infections and/ or functional tissue remodelling in the interior of the human body
03/02/2005EP1169065B1 Methacoline or histamine formulations for detecting asthma
03/02/2005EP1140017B1 Water-insoluble drug delivery system
1 ... 1853 1854 1855 1856 1857 1858 1859 1860 1861 1862 1863 1864 1865 1866 1867 1868 1869 1870 1871 1872 1873 ... 2991